{"id":144464,"date":"2025-02-06T12:39:24","date_gmt":"2025-02-06T07:09:24","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=144464"},"modified":"2025-02-06T13:35:03","modified_gmt":"2025-02-06T08:05:03","slug":"pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/","title":{"rendered":"Pharma stock jumps 17% after announcing Q3 results and dividend; Check the details"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3142366323\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Pharma stock that deals in the business of manufacturing generic API and its&nbsp; Intermediates, Xanthine derivatives, and offers CDMO or CMO services, was up 17 percent after reporting net profit growth of 40 percent year over year and dividend announcement.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3907112173\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price Movement<\/strong><\/h2><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/AARTIPHARM\" target=\"_blank\" rel=\"noreferrer noopener\">Aarti Pharmalabs Limited<\/a><\/strong>&#8216;s stock in Thursday\u2019s session touched a day\u2019s high of Rs. 747.15 per share up by 17.19 percent. The stock reiterated from the day\u2019s high and was trading at Rs. 679.25 which is 6.54 percent higher than the previous closing price of Rs. 637.55. The stock has delivered a return of around 24 percent in the past year and has outperformed the Nifty Index in the same period.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financial Performance<\/strong><\/h2><p>Their Q3FY25 results show revenue from operations of Rs. 537.77 crore which increased by 19.85 percent year on year, from Rs. 448.69 crore in Q3FY24 and a 17.41 percent increase from Rs. 458.02 crore in Q2FY25.&nbsp;<\/p><p>Their net profit increased by 40.22 percent year on year, from Rs. 52.76 crores in Q3FY24 to Rs. 73.98 crores in Q3FY25. Quarterly, the profits increased by 35.45 percent from Rs. 54.62 crore.<\/p><div class=\"trade-content_5\" id=\"trade-215702099\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Dividend Annoucements<\/strong><\/h2><p>The company\u2019s board of directors has declared an interim dividend of Rs. 2.5 per equity share which is 50 percent on the face value of Rs. 5 per share for FY25. The record date for the same is on Friday, February 14, 2025.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Future Outlook<\/strong>&nbsp;<\/h2><p>They expect EBITDA growth of approximately 10 to 12 percent in FY25. Further, they plan to lead the market in the Xanthine segment through brownfield expansion. The ongoing capex for the Atali project which plans to add 400+ KL reactor volume in Phase 1 holds scope for further expansions. They expect it to be commercialized in Q4FY25.<\/p><h2 class=\"wp-block-heading\"><strong>Company Overview&nbsp;<\/strong><\/h2><p>Aarti Pharmalabs was established in 1984 and was demerged from Aarti Industries in October 2022. It is a leading Indian manufacturer of APIs, intermediates, and nutraceuticals with a global presence while offering CDMO services.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Santhosh S<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-1631023904\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Pharma stock that deals in the business of manufacturing generic API and its&nbsp; Intermediates, Xanthine derivatives, and offers CDMO or CMO services, was up 17 percent after reporting net profit growth of 40 percent year over year and dividend announcement. Price Movement Aarti Pharmalabs Limited&#8216;s stock in Thursday\u2019s session touched a day\u2019s high of Rs. [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[18462,25930,18167,18463,6616,948,936,2597],"class_list":["post-144464","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-aarti-pharmalabs","tag-aarti-pharmalabs-limited","tag-aarti-pharmalabs-news","tag-aarti-pharmalabs-share-price","tag-pharma-stock","tag-stock-market","tag-stock-market-news","tag-stocks-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 17% after announcing Q3 results and dividend; Check the details - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Pharma stock that deals in the business of manufacturing generic API and its\u00a0 Intermediates, Xanthine derivatives, and offers CDMO or CMO services, was up 17 percent after reporting net profit growth of 40 percent year over year and dividend announcement.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 17% after announcing Q3 results and dividend; Check the details\" \/>\n<meta property=\"og:description\" content=\"Pharma stock that deals in the business of manufacturing generic API and its\u00a0 Intermediates, Xanthine derivatives, and offers CDMO or CMO services, was up 17 percent after reporting net profit growth of 40 percent year over year and dividend announcement.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-06T07:09:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-06T08:05:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/\",\"name\":\"Pharma stock jumps 17% after announcing Q3 results and dividend; Check the details - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2025-02-06T07:09:24+00:00\",\"dateModified\":\"2025-02-06T08:05:03+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Pharma stock that deals in the business of manufacturing generic API and its\u00a0 Intermediates, Xanthine derivatives, and offers CDMO or CMO services, was up 17 percent after reporting net profit growth of 40 percent year over year and dividend announcement.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 17% after announcing Q3 results and dividend; Check the details\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 17% after announcing Q3 results and dividend; Check the details - Trade Brains Features","description":"Pharma stock that deals in the business of manufacturing generic API and its\u00a0 Intermediates, Xanthine derivatives, and offers CDMO or CMO services, was up 17 percent after reporting net profit growth of 40 percent year over year and dividend announcement.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 17% after announcing Q3 results and dividend; Check the details","og_description":"Pharma stock that deals in the business of manufacturing generic API and its\u00a0 Intermediates, Xanthine derivatives, and offers CDMO or CMO services, was up 17 percent after reporting net profit growth of 40 percent year over year and dividend announcement.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-02-06T07:09:24+00:00","article_modified_time":"2025-02-06T08:05:03+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/","name":"Pharma stock jumps 17% after announcing Q3 results and dividend; Check the details - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2025-02-06T07:09:24+00:00","dateModified":"2025-02-06T08:05:03+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Pharma stock that deals in the business of manufacturing generic API and its\u00a0 Intermediates, Xanthine derivatives, and offers CDMO or CMO services, was up 17 percent after reporting net profit growth of 40 percent year over year and dividend announcement.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-17-after-announcing-q4-results-and-dividend-check-the-details\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 17% after announcing Q3 results and dividend; Check the details"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=144464"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144464\/revisions"}],"predecessor-version":[{"id":144468,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144464\/revisions\/144468"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=144464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=144464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=144464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}